In light of the dramatic protection from the occurrence of obesity-associated insulin resistance in conventional JNK-1-, but not JNK-2-deficient animals, JNK-1 was predicted to play an important role - particularly in the insulin-sensitive target tissue skeletal muscle - to cause obesity-associated insulin resistance [12]. This evidence concerns the gene MAPK9 and obesity disorder.